Abyrx
Irvington
About Abyrx
Abyrx acquisition of the HEMASORB Resorbable Hemostatic Bone Putty portfolio and the right to develop Bezwada Biomedical’s polymer technology for bone applications. The Company develops, manufactures, and provides therapeutic devices for use during surgical procedures.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Funding stage: M&A
- Last round: Series Unknown (Dec 2016)
- Website: abyrx.com
- Phone: (888)445-6784
Industries & Categories
Biotechnology, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/abyrx-42015 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.